These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31220260)

  • 1. Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects.
    Katsube T; Saisho Y; Shimada J; Furuie H
    J Antimicrob Chemother; 2019 Jul; 74(7):1971-1974. PubMed ID: 31220260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapulmonary Pharmacokinetic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients With Pneumonia and Healthy Subjects.
    Kawaguchi N; Katsube T; Echols R; Wajima T; Nicolau DP
    J Clin Pharmacol; 2022 May; 62(5):670-680. PubMed ID: 34648652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects.
    Saisho Y; Katsube T; White S; Fukase H; Shimada J
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
    Katsube T; Nicolau DP; Rodvold KA; Wunderink RG; Echols R; Matsunaga Y; Menon A; Portsmouth S; Wajima T
    J Antimicrob Chemother; 2021 Oct; 76(11):2902-2905. PubMed ID: 34383901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult Subjects.
    Sanabria C; Migoya E; Mason JW; Stanworth SH; Katsube T; Machida M; Narukawa Y; Den Nagata T
    Clin Ther; 2019 Sep; 41(9):1724-1736.e4. PubMed ID: 31378318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetic Analysis of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Healthy Subjects, Subjects with Various Degrees of Renal Function, and Patients with Complicated Urinary Tract Infection or Acute Uncomplicated Pyelonephritis.
    Kawaguchi N; Katsube T; Echols R; Wajima T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29038272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.
    Chandorkar G; Huntington JA; Gotfried MH; Rodvold KA; Umeh O
    J Antimicrob Chemother; 2012 Oct; 67(10):2463-9. PubMed ID: 22773741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.
    Rodvold KA; Bader J; Bruss JB; Hamed K
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0042623. PubMed ID: 37338378
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Nakamura R; Ito-Horiyama T; Takemura M; Toba S; Matsumoto S; Ikehara T; Tsuji M; Sato T; Yamano Y
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogens.
    Jorda A; Zeitlinger M
    Expert Rev Clin Pharmacol; 2021 Jul; 14(7):777-791. PubMed ID: 33849355
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefiderocol: A Siderophore Cephalosporin.
    El-Lababidi RM; Rizk JG
    Ann Pharmacother; 2020 Dec; 54(12):1215-1231. PubMed ID: 32522005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Patel A; Chavan R; Yeole R; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function.
    Katsube T; Wajima T; Ishibashi T; Arjona Ferreira JC; Echols R
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial.
    Portsmouth S; van Veenhuyzen D; Echols R; Machida M; Ferreira JCA; Ariyasu M; Tenke P; Nagata TD
    Lancet Infect Dis; 2018 Dec; 18(12):1319-1328. PubMed ID: 30509675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefiderocol, a Siderophore Cephalosporin for Gram-Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment.
    Katsube T; Echols R; Arjona Ferreira JC; Krenz HK; Berg JK; Galloway C
    J Clin Pharmacol; 2017 May; 57(5):584-591. PubMed ID: 27874971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.
    Rodvold KA; Yoo L; George JM
    Clin Pharmacokinet; 2011 Nov; 50(11):689-704. PubMed ID: 21973267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interaction of cefiderocol, a siderophore cephalosporin, via human drug transporters.
    Katsube T; Miyazaki S; Narukawa Y; Hernandez-Illas M; Wajima T
    Eur J Clin Pharmacol; 2018 Jul; 74(7):931-938. PubMed ID: 29627897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.